Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 2/10

vs
industry
vs
history
Cash-to-Debt 0.13
AMRS's Cash-to-Debt is ranked lower than
100% of the 1086 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.93 vs. AMRS: 0.13 )
Ranked among companies with meaningful Cash-to-Debt only.
AMRS' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.05  Med: 0.45 Max: 20.49
Current: 0.13
0.05
20.49
Equity-to-Asset -1.42
AMRS's Equity-to-Asset is ranked lower than
99% of the 1047 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.56 vs. AMRS: -1.42 )
Ranked among companies with meaningful Equity-to-Asset only.
AMRS' s Equity-to-Asset Range Over the Past 10 Years
Min: -1.49  Med: -0.58 Max: 0.86
Current: -1.42
-1.49
0.86
Piotroski F-Score: 5
Altman Z-Score: -13.40
Beneish M-Score: -3.60
WACC vs ROIC
9.28%
-1209.44%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating Margin % -142.76
AMRS's Operating Margin % is ranked lower than
96% of the 1061 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 7.15 vs. AMRS: -142.76 )
Ranked among companies with meaningful Operating Margin % only.
AMRS' s Operating Margin % Range Over the Past 10 Years
Min: -434.9  Med: -230.69 Max: -98.14
Current: -142.76
-434.9
-98.14
Net Margin % -144.86
AMRS's Net Margin % is ranked lower than
96% of the 1063 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 5.22 vs. AMRS: -144.86 )
Ranked among companies with meaningful Net Margin % only.
AMRS' s Net Margin % Range Over the Past 10 Years
Min: -638.16  Med: -144.86 Max: 5.28
Current: -144.86
-638.16
5.28
ROA % -89.56
AMRS's ROA % is ranked lower than
98% of the 1087 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 4.37 vs. AMRS: -89.56 )
Ranked among companies with meaningful ROA % only.
AMRS' s ROA % Range Over the Past 10 Years
Min: -135.25  Med: -58.34 Max: 1.1
Current: -89.56
-135.25
1.1
ROC (Joel Greenblatt) % -97.42
AMRS's ROC (Joel Greenblatt) % is ranked lower than
95% of the 1079 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 13.62 vs. AMRS: -97.42 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
AMRS' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -193.95  Med: -144.21 Max: 25.82
Current: -97.42
-193.95
25.82
3-Year Revenue Growth Rate -22.50
AMRS's 3-Year Revenue Growth Rate is ranked lower than
97% of the 929 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.60 vs. AMRS: -22.50 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
AMRS' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 0  Med: -52.9 Max: -22.5
Current: -22.5
3-Year EBITDA Growth Rate -59.80
AMRS's 3-Year EBITDA Growth Rate is ranked lower than
96% of the 830 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 8.90 vs. AMRS: -59.80 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
AMRS' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 0  Med: -35.4 Max: -17.7
Current: -59.8
3-Year EPS without NRI Growth Rate -47.90
AMRS's 3-Year EPS without NRI Growth Rate is ranked lower than
87% of the 756 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 9.40 vs. AMRS: -47.90 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
AMRS' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 0  Med: -37.35 Max: -21.5
Current: -47.9
GuruFocus has detected 3 Warning Signs with Amyris Inc $AMRS.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» AMRS's 10-Y Financials

Financials (Next Earnings Date: 2017-06-02 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Insider Trades

Latest Guru Trades with AMRS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Chemicals » Specialty Chemicals    NAICS: 325199    SIC: 2899
Compare:NAS:GURE, OTCPK:CXUSF, OTCPK:LWLG, NAS:NTIC, NAS:SYMX, OTCPK:LPAD, OTCPK:LQMT, OTCPK:APGMF, NAS:SNMX, NAS:TVIA, OTCPK:HDGHF, OTCPK:DTRX, OTCPK:NNOMF, NAS:TORM, NAS:DELT, NAS:AMTX, OTCPK:NANX, AMEX:FSI, NAS:IKNX, NAS:YTEN » details
Traded in other countries:3A0.Germany,
Headquarter Location:USA
Amyris Inc is a renewable products company engaged in providing sustainable alternatives to petroleum-sourced products. It developed microbial engineering and screening technologies that modify the way microorganisms process sugars.

Amyris Biotechnologies is a renewable products company. By applying its industrial synthetic biology technology platform, Amyris provides alternatives to select petroleum-sourced products. It produces and sells target molecules which replace chemicals and fuels that are made from petroleum. The company currently does not have any efforts on the commercial level in place, but hopes to bring its products to market by 2011.

Top Ranked Articles about Amyris Inc

SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Amyris, Inc. (Nasdaq: AMRS) To Contact Brower Piven Before The Lead Plaintiff Deadline
IMPORTANT AMYRIS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California against Amyris, Inc.
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Amyris, Inc. To Contact The Firm
Amyris Agrees to Exclusive China Manufacturing with Blue California Enabling Continued Record Product Revenue Growth into Asian Markets
Amyris’s Biossance Delivers Record First-Quarter Sales – #1 Eye Product at Sephora and On Track for Much Better than Expected 2017
Amyris Enables Launch of New High-Performance Tackifier from Cray Valley Featuring Sustainably-Sourced Resin Technology
Amyris & Kuraray Deliver Superior Performance in Sumitomo’s Dunlop Winter Maxx 02 Car Tires Driving Accelerated Growth for Amyris

Rolling on Liquid Farnesene Rubber Renewable Additive Improves Tire’s Ice Grip Performance at Low Temperatures

EMERYVILLE, Calif., March 06, 2017 (GLOBE NEWSWIRE) -- Amyris, Inc. (NASDAQ:AMRS), the industrial bioscience company, today announced that Sumitomo Rubber Industries, Ltd. (TYO:5110) has adopted liquid farnesene rubber (LFR) as a performance enhancing additive for use in the production of its latest Dunlop-branded Winter Maxx 02 tires. LFR is a liquid rubber developed by Kuraray Co., LTD (TYO:3405) using Amyris’s biologically derived Biofene® branded farnesene. The Winter Maxx 02 represents the brand’s best tire to date for on-ice and snow-braking performance and for durability. LFR’s breakthrough performance enhancement will be available across Dunlop’s entire Winter Maxx 02 portfolio of 91 sizes.
“We are excited to join with Kuraray in bringing LFR to the large global tire market and commercializing safer high-performance tires that utilize an additive from a sustainable resource,” said John Melo, President & CEO of Amyris. “This marks the first global tire brand to adopt our disruptive technology to deliver innovation. The better than expected results from this first launch are leading to significantly better early sales of LFR than we expected. We expect this commercial entry is just the start of anticipated adoption by other major brands across the world.” The unique qualities of farnesene material, which is only available at commercial scale from Amyris, is propelling product innovation and rapidly growing demand from the company’s customers. This has helped support Amyris’s ability to post significant revenue growth for 2016 with expectations that product revenues will continue to significantly expand. Biofene Amyris’s sugar cane-derived Biofene forms the basis for a wide range of products varying from specialty products such as cosmetics, perfumes, detergents and industrial lubricants, to transportation fuels such as diesel and jet fuel. As a tailor made pure hydrocarbon it provides numerous advantages when compared to petroleum-based oils and chemicals and is renewable, contributing to a sustainable future. LFR Features A proprietary liquid rubber using farnesene manufactured from sugar cane using fermentation technology.
 A viscosity that is much lower compared with current liquid isoprene rubber making it easier for rubber product manufacturers to use. In addition, it maintains excellent flexibility, even at low temperatures.
 Its unique chemical structure reacts completely with solid rubber during processing, meaning that, unlike oil additives it stays bonded, keeping tires softer, longer. In tires, its ice grip performance is maintained over many years. About Amyris Amyris is the integrated renewable products company that is enabling the world's leading brands to achieve sustainable growth. Amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products. The company is delivering its No Compromise® products across a number of markets, including specialty and performance chemicals, flavors and fragrances, cosmetics ingredients, pharmaceuticals, and nutraceuticals. More information about the company is available at www.amyris.com. Forward-Looking Statements This release contains forward-looking statements, and any statements other than statements of historical facts could be deemed to be forward-looking statements. These forward-looking statements include, among other things, statements regarding future events (such as the expected availability of LFR in Dunlop tires, anticipated adoption of LFR by other major brands, expected product innovation and growth in demand from Amyris’s customers, and anticipated growth in Amyris’s product revenues) that involve risks and uncertainties. These statements are based on management's current expectations and actual results and future events may differ materially due to risks and uncertainties, including risks related to manufacturing capacity at Amyris’s Brotas facility, delays or failures in development, production and commercialization of products, liquidity and ability to fund capital expenditures, Amyris’s reliance on third parties to achieve its goals, and other risks detailed in the “Risk Factors” section of Amyris’s quarterly report on Form 10-Q filed on November 9, 2016. Amyris disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events, or otherwise. Amyris, the Amyris logo and Biofene are registered trademarks of Amyris, Inc. All other trademarks are trademarks of their respective owners.
Contact:
Peter DeNardo
Director, Investor Relations and Corporate Communications
Amyris, Inc.
1 (510) 740-7481
[email protected]
[email protected]

Read more...

Ratios

vs
industry
vs
history
PS Ratio 2.06
AMRS's PS Ratio is ranked lower than
64% of the 1035 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.34 vs. AMRS: 2.06 )
Ranked among companies with meaningful PS Ratio only.
AMRS' s PS Ratio Range Over the Past 10 Years
Min: 0.52  Med: 3.44 Max: 9.58
Current: 2.06
0.52
9.58
EV-to-EBIT -5.94
AMRS's EV-to-EBIT is ranked lower than
99.99% of the 1124 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 16.80 vs. AMRS: -5.94 )
Ranked among companies with meaningful EV-to-EBIT only.
AMRS' s EV-to-EBIT Range Over the Past 10 Years
Min: -275.9  Med: -2.4 Max: 15
Current: -5.94
-275.9
15
EV-to-EBITDA -7.35
AMRS's EV-to-EBITDA is ranked lower than
99.99% of the 1142 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 12.25 vs. AMRS: -7.35 )
Ranked among companies with meaningful EV-to-EBITDA only.
AMRS' s EV-to-EBITDA Range Over the Past 10 Years
Min: -27.2  Med: -2.5 Max: 35.2
Current: -7.35
-27.2
35.2
Current Ratio 0.54
AMRS's Current Ratio is ranked lower than
99% of the 957 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.86 vs. AMRS: 0.54 )
Ranked among companies with meaningful Current Ratio only.
AMRS' s Current Ratio Range Over the Past 10 Years
Min: 0.46  Med: 1.51 Max: 9.91
Current: 0.54
0.46
9.91
Quick Ratio 0.48
AMRS's Quick Ratio is ranked lower than
99% of the 957 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.36 vs. AMRS: 0.48 )
Ranked among companies with meaningful Quick Ratio only.
AMRS' s Quick Ratio Range Over the Past 10 Years
Min: 0.31  Med: 1.41 Max: 9.77
Current: 0.48
0.31
9.77
Days Inventory 54.84
AMRS's Days Inventory is ranked higher than
61% of the 1022 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 65.16 vs. AMRS: 54.84 )
Ranked among companies with meaningful Days Inventory only.
AMRS' s Days Inventory Range Over the Past 10 Years
Min: 11.23  Med: 50.01 Max: 139.58
Current: 54.84
11.23
139.58
Days Sales Outstanding 71.19
AMRS's Days Sales Outstanding is ranked lower than
85% of the 858 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 59.97 vs. AMRS: 71.19 )
Ranked among companies with meaningful Days Sales Outstanding only.
AMRS' s Days Sales Outstanding Range Over the Past 10 Years
Min: 7.75  Med: 23.7 Max: 73.27
Current: 71.19
7.75
73.27
Days Payable 98.63
AMRS's Days Payable is ranked higher than
83% of the 814 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 49.46 vs. AMRS: 98.63 )
Ranked among companies with meaningful Days Payable only.
AMRS' s Days Payable Range Over the Past 10 Years
Min: 10.32  Med: 62.14 Max: 98.63
Current: 98.63
10.32
98.63

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -50.80
AMRS's 3-Year Average Share Buyback Ratio is ranked lower than
96% of the 486 Companies
in the Global Specialty Chemicals industry.

( Industry Median: -1.60 vs. AMRS: -50.80 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
AMRS' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -143.6  Med: -32.35 Max: 0
Current: -50.8
-143.6
0

Valuation & Return

vs
industry
vs
history
Price-to-Median-PS-Value 0.60
AMRS's Price-to-Median-PS-Value is ranked higher than
95% of the 952 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.32 vs. AMRS: 0.60 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
AMRS' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.6  Med: 1.02 Max: 2.81
Current: 0.6
0.6
2.81
Earnings Yield (Greenblatt) % -16.84
AMRS's Earnings Yield (Greenblatt) % is ranked lower than
95% of the 1290 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 5.25 vs. AMRS: -16.84 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
AMRS' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -16.84  Med: 7.7 Max: 8.7
Current: -16.84
-16.84
8.7

More Statistics

Revenue (TTM) (Mil) $67.19
EPS (TTM) $ -0.51
Beta-1.06
Short Percentage of Float4.41%
52-Week Range $0.31 - 1.21
Shares Outstanding (Mil)278.32

Analyst Estimate

Dec17 Dec18
Revenue (Mil $) 151 226
EPS ($) -0.21 -0.01
EPS without NRI ($) -0.21 -0.01
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)
» More Articles for AMRS

Headlines

Articles On GuruFocus.com
Lifshitz & Miller LLP Announces Investigation of Amyris, Inc., Commvault Systems, Inc., ICU Medical, Apr 28 2017 
IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against A Apr 28 2017 
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Amyris, Inc. To Apr 27 2017 
SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Apr 26 2017 
IMPORTANT AMYRIS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a se Apr 26 2017 
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Amy Apr 24 2017 
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Amyris, Inc. To Apr 20 2017 
Amyris Agrees to Exclusive China Manufacturing with Blue California Enabling Continued Record Produc Apr 18 2017 
Amyris’s Biossance Delivers Record First-Quarter Sales – #1 Eye Product at Sephora and On Apr 13 2017 
Amyris Enables Launch of New High-Performance Tackifier from Cray Valley Featuring Sustainably-Sourc Apr 03 2017 

More From Other Websites
Lifshitz & Miller LLP Announces Investigation of Amyris, Inc., Commvault Systems, Inc., ICU Medical,... Apr 28 2017
IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against... Apr 28 2017
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of... Apr 28 2017
IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against... Apr 27 2017
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Amyris, Inc. To... Apr 27 2017
AMRS LOSS NOTICE: Rosen Law Firm Reminds Amyris, Inc. Investors of the Important Deadline in First... Apr 27 2017
SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who... Apr 26 2017
IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against... Apr 26 2017
IMPORTANT AMYRIS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a... Apr 26 2017
IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Amyris,... Apr 26 2017
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against... Apr 26 2017
SHAREHOLDER ALERT: Goldberg Law PC Announces the Filing of a Securities Class Action Lawsuit against... Apr 24 2017
Robbins Arroyo LLP Is Investigating the Officers and Directors of Amyris, Inc. (AMRS) on Behalf of... Apr 24 2017
IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against... Apr 24 2017
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against... Apr 24 2017
ETFs with exposure to Amyris, Inc. : April 24, 2017 Apr 24 2017
IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Amyris,... Apr 21 2017
Pawar Law Group Announces Filing of Securities Class Action Lawsuit Against Amyris, Inc. - AMRS Apr 21 2017
INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Amyris, Inc.... Apr 21 2017
Amyris, Inc. :AMRS-US: Earnings Analysis: Q4, 2016 By the Numbers : April 21, 2017 Apr 21 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)